Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
The Journal of Investigative Dermatology
|
September 4, 2022
The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma
Irene Lasheras-Otero, Iker Feliu, Alberto Maillo, et al.
Cancers
|
September 23, 2022
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
Miriam Echaide, Ibone Labiano, Marina Delgado, et al.
International Journal of Molecular Sciences
|
April 17, 2019
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
Ana Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, et al.
International Journal of Molecular Sciences
|
September 9, 2022
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, et al.
International Journal of Molecular Sciences
|
September 9, 2022
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti, et al.
EMBO Molecular Medicine
|
July 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, et al.
Oncology and Therapy
|
December 12, 2022
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
Adrián Alegre, Gonzalo Benzo, Rafael Alonso, et al.
Journal of Personalized Medicine
|
July 2, 2021
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
Ester Blanco, Maria Ibañez-Vea, Carlos Hernandez, et al.
EMBO Reports
|
June 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona, et al.
British Journal of Cancer
|
December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
Carolyn J Edwards, Angelica Sette, Carl Cox, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
The Journal of Investigative Dermatology
|
September 4, 2022
The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma
Irene Lasheras-Otero, Iker Feliu, Alberto Maillo, et al.
Cancers
|
September 23, 2022
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
Miriam Echaide, Ibone Labiano, Marina Delgado, et al.
International Journal of Molecular Sciences
|
April 17, 2019
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
Ana Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, et al.
International Journal of Molecular Sciences
|
September 9, 2022
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, et al.
International Journal of Molecular Sciences
|
September 9, 2022
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti, et al.
EMBO Molecular Medicine
|
July 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, et al.
Oncology and Therapy
|
December 12, 2022
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
Adrián Alegre, Gonzalo Benzo, Rafael Alonso, et al.
Journal of Personalized Medicine
|
July 2, 2021
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
Ester Blanco, Maria Ibañez-Vea, Carlos Hernandez, et al.
EMBO Reports
|
June 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona, et al.
British Journal of Cancer
|
December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
Carolyn J Edwards, Angelica Sette, Carl Cox, et al.
Page
of 4